Tamoxifen versus toremifene in the adjuvant treatment of breast cancer

被引：0

作者：

Holli, K ^{[1
]}

机构：

[1] Univ Tampere, FIN-33101 Tampere, Finland

来源：

EUROPEAN JOURNAL OF CANCER | 2002年 / 38卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S37 / S38

页数：2

共 5 条

[1]

*EARL BREAST CANC, 2000, LANCET, V351, P1451

[2]

ELLMEN J, 1998, CANCER CHEMOTH PHARM, V45, P402

[3] Safety and efficacy results of a randomized trial comparing adjuvant toremifene and tamoxifen in postmenopausal patients with node-positive breast cancer [J].

Holli, K ;

Valavaara, R ;

Blanco, G ;

Kataja, V ;

Hietanen, P ;

Flander, M ;

Pukkala, E ;

Joensuu, H .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) :3487-3494

[4] ANTIESTROGENIC POTENCY OF TOREMIFENE AND TAMOXIFEN IN POSTMENOPAUSAL WOMEN [J].

HOMESLEY, HD ;

SHEMANO, I ;

GAMS, RA ;

HARRY, DS ;

HICKOX, PG ;

REBAR, RW ;

BUMP, RC ;

MULLIN, TJ ;

WENTZ, AC ;

OTOOLE, RV ;

LOVELACE, JV ;

LYDEN, C .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (02) :117-122

[5] A NEW TRIPHENYLETHYLENE COMPOUND, FC-1157A .2. ANTITUMOR EFFECTS [J].

KANGAS, L ;

NIEMINEN, AL ;

BLANCO, G ;

GRONROOS, M ;

KALLIO, S ;

KARJALAINEN, A ;

PERILA, M ;

SODERVALL, M ;

TOIVOLA, R .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 17 (02) :109-113

← 1 →